# pathway_0073: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/pathway_0073.txt)

**Task:** `pathway`  
**Author key, unchanged:** **D** — Secondary metabolite biosynthesis

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | usable output (valid_review) |
| after | GPT-6 Luna | supported | reasoning-supported | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MLNLTNVDDALHKGEEWLETNKKTFLSETETGISFKDNFADLLLLELSNRWDYPVIVPEDYPEDNDTNAVAFSILKPTDSRAKVLIDEILACKNADGIVQVHLDPNRPRIAPEVSANILSLFYSYGRGHEVQESLSYLQKAMALEEYQESRYYFLPEPLFFYTWRLLCIASGSALETIDNQRLPKELHTLRDHLIRRVSARLGTAKDNALCPALRILICHSLGIKNDVDLQLLLDLQEDDGSFGRAWFEGLDPSSARLHERGLHAARKTENNPRPPSDMQQRIHDPQMQYARWSDWPLAPSIARNDKGIQHDHHTLGSLESPRPSHDLLLLHH

[Multiple Choices]
A. L-isoleucine biosynthesis
B. L-isoleucine from 2-oxobutanoate: step 3/4. .
C. Antibiotic biosynthesis. .
D. Secondary metabolite biosynthesis
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence exactly matches the UniProt entry annotated as terpene cyclase vviB, with the pathway listed as secondary metabolite biosynthesis and terpenoid biosynthesis. The pathway annotation cites experimental evidence from a publication; this supports D for this protein, though the primary study was not independently reviewed here.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence and choices alone provide no sufficiently specific biological clue to identify this protein as a terpene cyclase in a secondary-metabolite pathway rather than an enzyme in one of the other listed pathways.


**Missing item-specific fact**

> The protein-specific functional/pathway annotation or equivalent experimental characterization identifying vviB as a terpene cyclase involved in terpenoid biosynthesis.


**Reason**

> The matching pathway annotation supports the key, but that information is reviewer-only. Recognizing the exact sequence or relying on a general sequence-based prediction would not supply a concrete distinguishing argument from the question input.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The evidence specifically associates this protein with terpenoid secondary-metabolite biosynthesis; it does not support the isoleucine or antibiotic-biosynthesis choices. D is the matching broad pathway option.


### Important caveats

- The historical UniProt record also matches the supplied sequence and gives the pathway annotation, but the author's exact source snapshot is unknown.
- The cited evidence code indicates experimental support in the database annotation; the cited publication was not independently validated in this review.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence and choices alone provide no sufficiently specific biological clue to identify this protein as a terpene cyclase in a secondary-metabolite pathway rather than an enzyme in one of the other listed pathways.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific functional/pathway annotation or equivalent experimental characterization identifying vviB as a terpene cyclase involved in terpenoid biosynthesis.",
    "reason": "The matching pathway annotation supports the key, but that information is reviewer-only. Recognizing the exact sequence or relying on a general sequence-based prediction would not supply a concrete distinguishing argument from the question input."
  },
  "case_id": "pathway_0073",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The sequence exactly matches the UniProt entry annotated as terpene cyclase vviB, with the pathway listed as secondary metabolite biosynthesis and terpenoid biosynthesis. The pathway annotation cites experimental evidence from a publication; this supports D for this protein, though the primary study was not independently reviewed here."
  },
  "important_caveats": [
    "The historical UniProt record also matches the supplied sequence and gives the pathway annotation, but the author's exact source snapshot is unknown.",
    "The cited evidence code indicates experimental support in the database annotation; the cited publication was not independently validated in this review."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The evidence specifically associates this protein with terpenoid secondary-metabolite biosynthesis; it does not support the isoleucine or antibiotic-biosynthesis choices. D is the matching broad pathway option."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0073",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence exactly matches the UniProt entry annotated as terpene cyclase vviB, with the pathway listed as secondary metabolite biosynthesis and terpenoid biosynthesis. The pathway annotation cites experimental evidence from a publication; this supports D for this protein, though the primary study was not independently reviewed here.",
    "evidence_ids": ["C1", "C4", "C5", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence and choices alone provide no sufficiently specific biological clue to identify this protein as a terpene cyclase in a secondary-metabolite pathway rather than an enzyme in one of the other listed pathways.",
    "missing_item_specific_fact": "The protein-specific functional/pathway annotation or equivalent experimental characterization identifying vviB as a terpene cyclase involved in terpenoid biosynthesis.",
    "reason": "The matching pathway annotation supports the key, but that information is reviewer-only. Recognizing the exact sequence or relying on a general sequence-based prediction would not supply a concrete distinguishing argument from the question input."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The evidence specifically associates this protein with terpenoid secondary-metabolite biosynthesis; it does not support the isoleucine or antibiotic-biosynthesis choices. D is the matching broad pathway option."
  },
  "important_caveats": [
    "The historical UniProt record also matches the supplied sequence and gives the pathway annotation, but the author's exact source snapshot is unknown.",
    "The cited evidence code indicates experimental support in the database annotation; the cited publication was not independently validated in this review."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry for this sequence (A0A6A6H2E0, VVIB_VIRVR) explicitly annotates the pathway as 'Secondary metabolite biosynthesis; terpenoid biosynthesis' with experimental evidence (ECO:0000269, PubMed:39310987). The protein is a terpene cyclase (EC 4.2.3.-) involved in Sporulositol A biosynthesis in the lichen-forming fungus Viridothelium virens. The expected answer D ('Secondary metabolite biosynthesis') is a direct match to the UniProt pathway annotation.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C4](#evidence-c4), [C6](#evidence-c6).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> A knowledgeable reader could weakly argue that the 333-aa sequence lacks ACT domains, threonine deaminase motifs, or other hallmarks of amino acid biosynthesis enzymes, making options A and B less plausible. However, distinguishing D (secondary metabolite biosynthesis) from C (antibiotic biosynthesis) requires knowing the specific product identity: Sporulositol A is a terpenoid classified under general secondary metabolite biosynthesis, not an antibiotic. This product-specific classification is not derivable from the sequence alone.


**Missing item-specific fact**

> The identification of this sequence as a terpene cyclase (vviB) and the experimental determination that its product, Sporulositol A, is a terpenoid secondary metabolite rather than an antibiotic. The sequence lacks obvious, widely-recognized terpene cyclase motifs (DDxxD, NSE/DTE triads) that would allow confident identification without database lookup or specialized training. The distinction between 'antibiotic biosynthesis' (C) and 'secondary metabolite biosynthesis' (D) depends on knowing the specific compound's classification from the 2024 Tang & Zou study.


**Reason**

> Without recognizing this as terpene cyclase vviB from Viridothelium virens and knowing that Sporulositol A is a non-antibiotic terpenoid, a model cannot reliably distinguish C from D. Both are plausible categories for a fungal terpene cyclase. The correct answer depends on the specific UniProt annotation derived from experimental work, not on generalizable sequence-based reasoning.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "C",
  "D"
]
```

> Both 'Antibiotic biosynthesis' (C) and 'Secondary metabolite biosynthesis' (D) are plausible for a fungal terpene cyclase. Antibiotic biosynthesis is a subset of secondary metabolite biosynthesis, and without knowing that Sporulositol A is specifically a terpenoid (not an antibiotic), a model could defensibly select either. The UniProt annotation resolves this in favor of D, but the sequence alone does not clearly exclude C.


### Important caveats

- The UniProt pathway annotation carries experimental evidence (ECO:0000269) from PubMed:39310987 (Tang & Zou, Org. Lett. 2024), making the key scientifically well-supported.
- The protein was integrated into Swiss-Prot only on 2025-04-09; the author's source snapshot is unknown. The annotation may not have been available at the time the benchmark was constructed.
- The sequence does not contain easily recognizable canonical terpene cyclase motifs (DDxxD, NSE/DTE) in an obvious arrangement, making de novo identification from sequence alone very difficult.
- Options A and B (L-isoleucine biosynthesis) are clearly incorrect for a terpene cyclase, serving as easy distractors.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "A knowledgeable reader could weakly argue that the 333-aa sequence lacks ACT domains, threonine deaminase motifs, or other hallmarks of amino acid biosynthesis enzymes, making options A and B less plausible. However, distinguishing D (secondary metabolite biosynthesis) from C (antibiotic biosynthesis) requires knowing the specific product identity: Sporulositol A is a terpenoid classified under general secondary metabolite biosynthesis, not an antibiotic. This product-specific classification is not derivable from the sequence alone.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The identification of this sequence as a terpene cyclase (vviB) and the experimental determination that its product, Sporulositol A, is a terpenoid secondary metabolite rather than an antibiotic. The sequence lacks obvious, widely-recognized terpene cyclase motifs (DDxxD, NSE/DTE triads) that would allow confident identification without database lookup or specialized training. The distinction between 'antibiotic biosynthesis' (C) and 'secondary metabolite biosynthesis' (D) depends on knowing the specific compound's classification from the 2024 Tang & Zou study.",
    "reason": "Without recognizing this as terpene cyclase vviB from Viridothelium virens and knowing that Sporulositol A is a non-antibiotic terpenoid, a model cannot reliably distinguish C from D. Both are plausible categories for a fungal terpene cyclase. The correct answer depends on the specific UniProt annotation derived from experimental work, not on generalizable sequence-based reasoning."
  },
  "case_id": "pathway_0073",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C4",
      "C6"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry for this sequence (A0A6A6H2E0, VVIB_VIRVR) explicitly annotates the pathway as 'Secondary metabolite biosynthesis; terpenoid biosynthesis' with experimental evidence (ECO:0000269, PubMed:39310987). The protein is a terpene cyclase (EC 4.2.3.-) involved in Sporulositol A biosynthesis in the lichen-forming fungus Viridothelium virens. The expected answer D ('Secondary metabolite biosynthesis') is a direct match to the UniProt pathway annotation."
  },
  "important_caveats": [
    "The UniProt pathway annotation carries experimental evidence (ECO:0000269) from PubMed:39310987 (Tang & Zou, Org. Lett. 2024), making the key scientifically well-supported.",
    "The protein was integrated into Swiss-Prot only on 2025-04-09; the author's source snapshot is unknown. The annotation may not have been available at the time the benchmark was constructed.",
    "The sequence does not contain easily recognizable canonical terpene cyclase motifs (DDxxD, NSE/DTE) in an obvious arrangement, making de novo identification from sequence alone very difficult.",
    "Options A and B (L-isoleucine biosynthesis) are clearly incorrect for a terpene cyclase, serving as easy distractors."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "C",
      "D"
    ],
    "reason": "Both 'Antibiotic biosynthesis' (C) and 'Secondary metabolite biosynthesis' (D) are plausible for a fungal terpene cyclase. Antibiotic biosynthesis is a subset of secondary metabolite biosynthesis, and without knowing that Sporulositol A is specifically a terpenoid (not an antibiotic), a model could defensibly select either. The UniProt annotation resolves this in favor of D, but the sequence alone does not clearly exclude C."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0073",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry for this sequence (A0A6A6H2E0, VVIB_VIRVR) explicitly annotates the pathway as 'Secondary metabolite biosynthesis; terpenoid biosynthesis' with experimental evidence (ECO:0000269, PubMed:39310987). The protein is a terpene cyclase (EC 4.2.3.-) involved in Sporulositol A biosynthesis in the lichen-forming fungus Viridothelium virens. The expected answer D ('Secondary metabolite biosynthesis') is a direct match to the UniProt pathway annotation.",
    "evidence_ids": ["C5", "H3", "C4", "C6"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "A knowledgeable reader could weakly argue that the 333-aa sequence lacks ACT domains, threonine deaminase motifs, or other hallmarks of amino acid biosynthesis enzymes, making options A and B less plausible. However, distinguishing D (secondary metabolite biosynthesis) from C (antibiotic biosynthesis) requires knowing the specific product identity: Sporulositol A is a terpenoid classified under general secondary metabolite biosynthesis, not an antibiotic. This product-specific classification is not derivable from the sequence alone.",
    "missing_item_specific_fact": "The identification of this sequence as a terpene cyclase (vviB) and the experimental determination that its product, Sporulositol A, is a terpenoid secondary metabolite rather than an antibiotic. The sequence lacks obvious, widely-recognized terpene cyclase motifs (DDxxD, NSE/DTE triads) that would allow confident identification without database lookup or specialized training. The distinction between 'antibiotic biosynthesis' (C) and 'secondary metabolite biosynthesis' (D) depends on knowing the specific compound's classification from the 2024 Tang & Zou study.",
    "reason": "Without recognizing this as terpene cyclase vviB from Viridothelium virens and knowing that Sporulositol A is a non-antibiotic terpenoid, a model cannot reliably distinguish C from D. Both are plausible categories for a fungal terpene cyclase. The correct answer depends on the specific UniProt annotation derived from experimental work, not on generalizable sequence-based reasoning."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["C", "D"],
    "reason": "Both 'Antibiotic biosynthesis' (C) and 'Secondary metabolite biosynthesis' (D) are plausible for a fungal terpene cyclase. Antibiotic biosynthesis is a subset of secondary metabolite biosynthesis, and without knowing that Sporulositol A is specifically a terpenoid (not an antibiotic), a model could defensibly select either. The UniProt annotation resolves this in favor of D, but the sequence alone does not clearly exclude C."
  },
  "important_caveats": [
    "The UniProt pathway annotation carries experimental evidence (ECO:0000269) from PubMed:39310987 (Tang & Zou, Org. Lett. 2024), making the key scientifically well-supported.",
    "The protein was integrated into Swiss-Prot only on 2025-04-09; the author's source snapshot is unknown. The annotation may not have been available at the time the benchmark was constructed.",
    "The sequence does not contain easily recognizable canonical terpene cyclase motifs (DDxxD, NSE/DTE) in an obvious arrangement, making de novo identification from sequence alone very difficult.",
    "Options A and B (L-isoleucine biosynthesis) are clearly incorrect for a terpene cyclase, serving as easy distractors."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched UniProt pathway annotation identifies secondary metabolite biosynthesis and cites experimental evidence (ECO:0000269). This supports choice D, although the cited paper was not independently reviewed here.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence is consistent with a soluble enzyme in the terpene-cyclase family. Transferable knowledge of terpene cyclases links that family to terpenoid and other specialized (secondary) metabolite biosynthesis, favoring D over isoleucine biosynthesis or an antibiotic-specific pathway. This is a probabilistic family-level inference, not a sequence-only proof of the exact pathway.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> A family-level inference from the sequence can meaningfully separate the broad secondary-metabolite option from the amino-acid options and the antibiotic-specific option, without relying on the target's recorded annotation.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Although antibiotic biosynthesis is one type of secondary metabolism, the evidence supports terpenoid/secondary-metabolite biosynthesis, not an antibiotic pathway specifically.


### Important caveats

- The pathway evidence is a database annotation citing a paper; that primary study was not independently assessed.
- The author's exact source snapshot is unknown.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is consistent with a soluble enzyme in the terpene-cyclase family. Transferable knowledge of terpene cyclases links that family to terpenoid and other specialized (secondary) metabolite biosynthesis, favoring D over isoleucine biosynthesis or an antibiotic-specific pathway. This is a probabilistic family-level inference, not a sequence-only proof of the exact pathway.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "A family-level inference from the sequence can meaningfully separate the broad secondary-metabolite option from the amino-acid options and the antibiotic-specific option, without relying on the target's recorded annotation."
  },
  "case_id": "pathway_0073",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched UniProt pathway annotation identifies secondary metabolite biosynthesis and cites experimental evidence (ECO:0000269). This supports choice D, although the cited paper was not independently reviewed here."
  },
  "important_caveats": [
    "The pathway evidence is a database annotation citing a paper; that primary study was not independently assessed.",
    "The author's exact source snapshot is unknown."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Although antibiotic biosynthesis is one type of secondary metabolism, the evidence supports terpenoid/secondary-metabolite biosynthesis, not an antibiotic pathway specifically."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0073",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched UniProt pathway annotation identifies secondary metabolite biosynthesis and cites experimental evidence (ECO:0000269). This supports choice D, although the cited paper was not independently reviewed here.",
    "evidence_ids": ["C5", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence is consistent with a soluble enzyme in the terpene-cyclase family. Transferable knowledge of terpene cyclases links that family to terpenoid and other specialized (secondary) metabolite biosynthesis, favoring D over isoleucine biosynthesis or an antibiotic-specific pathway. This is a probabilistic family-level inference, not a sequence-only proof of the exact pathway.",
    "missing_item_specific_fact": "",
    "reason": "A family-level inference from the sequence can meaningfully separate the broad secondary-metabolite option from the amino-acid options and the antibiotic-specific option, without relying on the target's recorded annotation."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Although antibiotic biosynthesis is one type of secondary metabolism, the evidence supports terpenoid/secondary-metabolite biosynthesis, not an antibiotic pathway specifically."
  },
  "important_caveats": [
    "The pathway evidence is a database annotation citing a paper; that primary study was not independently assessed.",
    "The author's exact source snapshot is unknown."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt annotation (evidence C5, H3) explicitly states the pathway as 'Secondary metabolite biosynthesis; terpenoid biosynthesis' with experimental evidence (ECO:0000269|PubMed:39310987). The protein is identified as Terpene cyclase vviB involved in Sporulositol A biosynthesis, a terpenoid secondary metabolite. Choice D matches this annotation exactly.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The 333-aa sequence contains aspartate-rich regions (e.g., 'LLDLQEDDGSFGRAW' with a DD motif) and NSE/DTE-like triad features (NADG...S...E/D spacing) consistent with terpene cyclase family members. From general knowledge of terpene cyclases across plants, fungi, and bacteria (hundreds of characterized examples), the canonical pathway annotation is 'Secondary metabolite biosynthesis; terpenoid biosynthesis' — NOT 'Antibiotic biosynthesis' (a narrower sub-category requiring evidence of antimicrobial product activity) and certainly not amino acid biosynthesis (A, B), which involves entirely different enzyme classes (dehydratases, reductoisomerases, transaminases). The DDxxD-like motif and appropriate length (~300-400 aa) are well-known family signatures learned from other terpene cyclases, and the pathway assignment follows the consistent pattern observed across the terpene cyclase superfamily.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> A model recognizing DDxxD-like motifs, NSE/DTE triad features, and the ~333-aa length as terpene cyclase signatures can apply the well-established pathway annotation pattern for this enzyme superfamily. The distinction between 'Secondary metabolite biosynthesis' (D) and 'Antibiotic biosynthesis' (C) follows from the general principle that terpene cyclases are annotated under the broad secondary metabolite pathway, while 'antibiotic biosynthesis' is a more specific category requiring product-level evidence. Options A and B are excluded because amino acid biosynthesis enzymes share no sequence similarity with terpene cyclases.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> While C (Antibiotic biosynthesis) is a subset of secondary metabolite biosynthesis and some terpenoids are antibiotics, the standard pathway annotation for terpene cyclases across databases is 'Secondary metabolite biosynthesis; terpenoid biosynthesis.' The DDxxD-like motif and family-level pathway assignment clearly favor D over C. Options A and B are unambiguously wrong for a terpene cyclase.


### Important caveats

- The classic DDxxD motif is present as DD but the terminal D substitution (DDGSF rather than DDxxD) makes motif-based identification less certain than for canonical terpene cyclases.
- The C-terminal histidine-rich region (HHTLGSLESPRPSHDLLLLHH) is atypical and could introduce some ambiguity about enzyme class if motifs alone are insufficient.
- The distinction between C and D relies on the general pathway-annotation convention for terpene cyclases rather than a unique sequence feature distinguishing this protein from antibiotic-producing enzymes.
- The protein was only annotated in Swiss-Prot as of January 2026 (entry version 12), so the specific pathway knowledge may depend on the model's training cutoff.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The 333-aa sequence contains aspartate-rich regions (e.g., 'LLDLQEDDGSFGRAW' with a DD motif) and NSE/DTE-like triad features (NADG...S...E/D spacing) consistent with terpene cyclase family members. From general knowledge of terpene cyclases across plants, fungi, and bacteria (hundreds of characterized examples), the canonical pathway annotation is 'Secondary metabolite biosynthesis; terpenoid biosynthesis' — NOT 'Antibiotic biosynthesis' (a narrower sub-category requiring evidence of antimicrobial product activity) and certainly not amino acid biosynthesis (A, B), which involves entirely different enzyme classes (dehydratases, reductoisomerases, transaminases). The DDxxD-like motif and appropriate length (~300-400 aa) are well-known family signatures learned from other terpene cyclases, and the pathway assignment follows the consistent pattern observed across the terpene cyclase superfamily.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "A model recognizing DDxxD-like motifs, NSE/DTE triad features, and the ~333-aa length as terpene cyclase signatures can apply the well-established pathway annotation pattern for this enzyme superfamily. The distinction between 'Secondary metabolite biosynthesis' (D) and 'Antibiotic biosynthesis' (C) follows from the general principle that terpene cyclases are annotated under the broad secondary metabolite pathway, while 'antibiotic biosynthesis' is a more specific category requiring product-level evidence. Options A and B are excluded because amino acid biosynthesis enzymes share no sequence similarity with terpene cyclases."
  },
  "case_id": "pathway_0073",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The UniProt annotation (evidence C5, H3) explicitly states the pathway as 'Secondary metabolite biosynthesis; terpenoid biosynthesis' with experimental evidence (ECO:0000269|PubMed:39310987). The protein is identified as Terpene cyclase vviB involved in Sporulositol A biosynthesis, a terpenoid secondary metabolite. Choice D matches this annotation exactly."
  },
  "important_caveats": [
    "The classic DDxxD motif is present as DD but the terminal D substitution (DDGSF rather than DDxxD) makes motif-based identification less certain than for canonical terpene cyclases.",
    "The C-terminal histidine-rich region (HHTLGSLESPRPSHDLLLLHH) is atypical and could introduce some ambiguity about enzyme class if motifs alone are insufficient.",
    "The distinction between C and D relies on the general pathway-annotation convention for terpene cyclases rather than a unique sequence feature distinguishing this protein from antibiotic-producing enzymes.",
    "The protein was only annotated in Swiss-Prot as of January 2026 (entry version 12), so the specific pathway knowledge may depend on the model's training cutoff."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "While C (Antibiotic biosynthesis) is a subset of secondary metabolite biosynthesis and some terpenoids are antibiotics, the standard pathway annotation for terpene cyclases across databases is 'Secondary metabolite biosynthesis; terpenoid biosynthesis.' The DDxxD-like motif and family-level pathway assignment clearly favor D over C. Options A and B are unambiguously wrong for a terpene cyclase."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0073",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt annotation (evidence C5, H3) explicitly states the pathway as 'Secondary metabolite biosynthesis; terpenoid biosynthesis' with experimental evidence (ECO:0000269|PubMed:39310987). The protein is identified as Terpene cyclase vviB involved in Sporulositol A biosynthesis, a terpenoid secondary metabolite. Choice D matches this annotation exactly.",
    "evidence_ids": ["C5", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The 333-aa sequence contains aspartate-rich regions (e.g., 'LLDLQEDDGSFGRAW' with a DD motif) and NSE/DTE-like triad features (NADG...S...E/D spacing) consistent with terpene cyclase family members. From general knowledge of terpene cyclases across plants, fungi, and bacteria (hundreds of characterized examples), the canonical pathway annotation is 'Secondary metabolite biosynthesis; terpenoid biosynthesis' — NOT 'Antibiotic biosynthesis' (a narrower sub-category requiring evidence of antimicrobial product activity) and certainly not amino acid biosynthesis (A, B), which involves entirely different enzyme classes (dehydratases, reductoisomerases, transaminases). The DDxxD-like motif and appropriate length (~300-400 aa) are well-known family signatures learned from other terpene cyclases, and the pathway assignment follows the consistent pattern observed across the terpene cyclase superfamily.",
    "missing_item_specific_fact": "",
    "reason": "A model recognizing DDxxD-like motifs, NSE/DTE triad features, and the ~333-aa length as terpene cyclase signatures can apply the well-established pathway annotation pattern for this enzyme superfamily. The distinction between 'Secondary metabolite biosynthesis' (D) and 'Antibiotic biosynthesis' (C) follows from the general principle that terpene cyclases are annotated under the broad secondary metabolite pathway, while 'antibiotic biosynthesis' is a more specific category requiring product-level evidence. Options A and B are excluded because amino acid biosynthesis enzymes share no sequence similarity with terpene cyclases."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "While C (Antibiotic biosynthesis) is a subset of secondary metabolite biosynthesis and some terpenoids are antibiotics, the standard pathway annotation for terpene cyclases across databases is 'Secondary metabolite biosynthesis; terpenoid biosynthesis.' The DDxxD-like motif and family-level pathway assignment clearly favor D over C. Options A and B are unambiguously wrong for a terpene cyclase."
  },
  "important_caveats": [
    "The classic DDxxD motif is present as DD but the terminal D substitution (DDGSF rather than DDxxD) makes motif-based identification less certain than for canonical terpene cyclases.",
    "The C-terminal histidine-rich region (HHTLGSLESPRPSHDLLLLHH) is atypical and could introduce some ambiguity about enzyme class if motifs alone are insufficient.",
    "The distinction between C and D relies on the general pathway-annotation convention for terpene cyclases rather than a unique sequence feature distinguishing this protein from antibiotic-producing enzymes.",
    "The protein was only annotated in Swiss-Prot as of January 2026 (entry version 12), so the specific pathway knowledge may depend on the model's training cutoff."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "A0A6A6H2E0",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "a1c09443fedcb62c00aaf145cd007a77c82a9540e45d597a989a1635abab7d2f",
  "benchmark_sequence_length": 333,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 14,
    "firstPublicDate": "2025-04-09",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2020-06-17",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "3d39951d8d42c448594f2eec6c6a9e2cec322a8340d79db22032e12c77f0af30",
  "current_source_sequence_sha256": "a1c09443fedcb62c00aaf145cd007a77c82a9540e45d597a989a1635abab7d2f",
  "current_source_sequence_length": 333,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 12,
  "selected_historical_version": {
    "accession": "A0A6A6H2E0",
    "database": "Swiss-Prot",
    "entryVersion": 12,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "VVIB_VIRVR",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "ba398b865fc9576814bd6954ed27346d14ab44b5850d578e50e8feb280836380",
  "selected_historical_source_sequence_sha256": "a1c09443fedcb62c00aaf145cd007a77c82a9540e45d597a989a1635abab7d2f",
  "selected_historical_source_sequence_length": 333,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 12,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A6A6H2E0.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A6A6H2E0.json",
  "source_sha256": "3d39951d8d42c448594f2eec6c6a9e2cec322a8340d79db22032e12c77f0af30",
  "retrieved_utc": "2026-11-02T04:25:29.065613+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"A0A6A6H2E0\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A6A6H2E0.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A6A6H2E0.json",
  "source_sha256": "3d39951d8d42c448594f2eec6c6a9e2cec322a8340d79db22032e12c77f0af30",
  "retrieved_utc": "2026-11-02T04:25:29.065613+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":14,\"firstPublicDate\":\"2025-04-09\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2020-06-17\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A6A6H2E0.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A6A6H2E0.json",
  "source_sha256": "3d39951d8d42c448594f2eec6c6a9e2cec322a8340d79db22032e12c77f0af30",
  "retrieved_utc": "2026-11-02T04:25:29.065613+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"commonName\":\"Speckled blister lichen\",\"lineage\":[\"Eukaryota\",\"Fungi\",\"Dikarya\",\"Ascomycota\",\"Pezizomycotina\",\"Dothideomycetes\",\"Dothideomycetes incertae sedis\",\"Trypetheliales\",\"Trypetheliaceae\",\"Viridothelium\"],\"scientificName\":\"Viridothelium virens\",\"synonyms\":[\"Trypethelium virens\"],\"taxonId\":1048519}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A6A6H2E0.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A6A6H2E0.json",
  "source_sha256": "3d39951d8d42c448594f2eec6c6a9e2cec322a8340d79db22032e12c77f0af30",
  "retrieved_utc": "2026-11-02T04:25:29.065613+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"39310987\",\"source\":\"PubMed\"}],\"value\":\"Sporulositol A biosynthesis cluster protein B\"}}],\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"39310987\",\"source\":\"PubMed\"}],\"value\":\"4.2.3.-\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"39310987\",\"source\":\"PubMed\"}],\"value\":\"Terpene cyclase vviB\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A6A6H2E0.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A6A6H2E0.json",
  "source_sha256": "3d39951d8d42c448594f2eec6c6a9e2cec322a8340d79db22032e12c77f0af30",
  "retrieved_utc": "2026-11-02T04:25:29.065613+00:00",
  "json_pointer": "/comments/2",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"39310987\",\"source\":\"PubMed\"}],\"value\":\"Secondary metabolite biosynthesis; terpenoid biosynthesis\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A6A6H2E0.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A6A6H2E0.json",
  "source_sha256": "3d39951d8d42c448594f2eec6c6a9e2cec322a8340d79db22032e12c77f0af30",
  "retrieved_utc": "2026-11-02T04:25:29.065613+00:00",
  "json_pointer": "/references/1",
  "excerpt": "{\"citation\":{\"authors\":[\"Tang Y.J.\",\"Zou Y.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"39310987\"},{\"database\":\"DOI\",\"id\":\"10.1021/acs.orglett.4c03154\"}],\"citationType\":\"journal article\",\"firstPage\":\"8366\",\"id\":\"39310987\",\"journal\":\"Org. Lett.\",\"lastPage\":\"8370\",\"publicationDate\":\"2024\",\"title\":\"Cyclo-farnesyl Diphosphate-Dependent Prenylation in Fungi.\",\"volume\":\"26\"},\"referenceNumber\":2,\"referencePositions\":[\"FUNCTION\",\"CATALYTIC ACTIVITY\",\"PATHWAY\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A6A6H2E0?format=txt&versions=12)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A6A6H2E0?format=txt&versions=12",
  "source_sha256": "ba398b865fc9576814bd6954ed27346d14ab44b5850d578e50e8feb280836380",
  "retrieved_utc": "2026-11-02T04:25:33.124614+00:00",
  "source_locator": "lines 1-14",
  "excerpt": "ID   VVIB_VIRVR              Reviewed;         333 AA.\nAC   A0A6A6H2E0;\nDT   09-APR-2025, integrated into UniProtKB/Swiss-Prot.\nDT   17-JUN-2020, sequence version 1.\nDT   28-JAN-2026, entry version 12.\nDE   RecName: Full=Terpene cyclase vviB {ECO:0000303|PubMed:39310987};\nDE            EC=4.2.3.- {ECO:0000269|PubMed:39310987};\nDE   AltName: Full=Sporulositol A biosynthesis cluster protein B {ECO:0000303|PubMed:39310987};\nGN   Name=vviB {ECO:0000303|PubMed:39310987}; ORFNames=EV356DRAFT_534741;\nOS   Viridothelium virens (Speckled blister lichen) (Trypethelium virens).\nOC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Dothideomycetes;\nOC   Dothideomycetes incertae sedis; Trypetheliales; Trypetheliaceae;\nOC   Viridothelium.\nOX   NCBI_TaxID=1048519;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 12,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A6A6H2E0?format=txt&versions=12)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A6A6H2E0?format=txt&versions=12",
  "source_sha256": "ba398b865fc9576814bd6954ed27346d14ab44b5850d578e50e8feb280836380",
  "retrieved_utc": "2026-11-02T04:25:33.124614+00:00",
  "source_locator": "lines 29-34",
  "excerpt": "RN   [2]\nRP   FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.\nRX   PubMed=39310987; DOI=10.1021/acs.orglett.4c03154;\nRA   Tang Y.J., Zou Y.;\nRT   \"Cyclo-farnesyl Diphosphate-Dependent Prenylation in Fungi.\";\nRL   Org. Lett. 26:8366-8370(2024).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 12,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A6A6H2E0?format=txt&versions=12)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A6A6H2E0?format=txt&versions=12",
  "source_sha256": "ba398b865fc9576814bd6954ed27346d14ab44b5850d578e50e8feb280836380",
  "retrieved_utc": "2026-11-02T04:25:33.124614+00:00",
  "source_locator": "lines 45-46",
  "excerpt": "CC   -!- PATHWAY: Secondary metabolite biosynthesis; terpenoid biosynthesis.\nCC       {ECO:0000269|PubMed:39310987}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 12,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 73. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
